Consolidated Statements of Equity - USD ($) $ in Thousands	Total	Common Stock Series A	Common Stock Series B	Additional paid-in capital	Accumulated deficit	Accumulated other comprehensive income	Noncontrolling interests	Treasury Stock	Treasury Stock Series B
Balance at Jul. 31, 2022	$ 97,206	$ 8	$ 237	$ 262,023	$ (165,457)	$ 3,704	$ (3,309)
Balance (in Shares) at Jul. 31, 2022		787,163	23,687,964
Net loss	(2,215)				(1,876)		(339)
Stock-based compensation	3,091		$ 2	3,089
Stock-based compensation (in Shares)			220,019
Forfeiture of restricted stock	(903)		$ (2)	(901)
Forfeiture of restricted stock (in Shares)			(296,759)
Shares withheld for payroll taxes	(218)		$ (1)	(217)
Shares withheld for payroll taxes (in Shares)			(120,697)
Unrealized gain on available-for-sale securities	(290)					(290)
Acquisition of additional ownership interest in LipoMedix				16			(16)
Foreign currency translation adjustment	(42)					(42)
Balance at Jul. 31, 2023	96,629	$ 8	$ 236	264,010	(167,333)	3,372	(3,664)
Balance (in Shares) at Jul. 31, 2023		787,163	23,490,527
Net loss	(65,003)				(34,410)		(30,593)
Stock-based compensation	2,296		$ 3	2,293
Stock-based compensation (in Shares)			506,826
Shares withheld for payroll taxes	(136)		$ (1)	(135)
Shares withheld for payroll taxes (in Shares)			(75,918)
Unrealized gain on available-for-sale securities	464					464
Sale of Rafael Medical Devices membership units	925			869			56
Noncontrolling interest in Day Three acquisition	1,151						1,151
Purchases of treasury stock	(168)							(168)
Purchases of treasury stock (in Shares)			(101,487)						101,487
Gain on RP Finance consolidation	7,600			7,600
Paid-in capital arising from Cornerstone Acquisition	7,260			7,260
Noncontrolling interest arising from Cornerstone Acquisition	27,501						27,501
Noncontrolling interest arising from RP Finance Consolidation	12,667						12,667
Elimination of RP Finance investment in Cornerstone	(4,931)			(1,849)			(3,082)
Dissolution of Levco	56					19	37
Foreign currency translation adjustment	(53)					(53)
Balance at Jul. 31, 2024	$ 86,258	$ 8	$ 238	$ 280,048	$ (201,743)	$ 3,802	$ 4,073	$ (168)
Balance (in Shares) at Jul. 31, 2024		787,163	23,819,948						101,487